| dc.contributor.author | Fernández Velasco, Pablo | |
| dc.contributor.author | Estévez Asensio, Lucía | |
| dc.contributor.author | Torres Torres, Beatriz | |
| dc.contributor.author | Ortolá Buigues, Ana | |
| dc.contributor.author | Gómez Hoyos, Emilia | |
| dc.contributor.author | Delgado García, Esther | |
| dc.contributor.author | Luis Román, Daniel Antonio de | |
| dc.contributor.author | Díaz Soto, Gonzalo | |
| dc.date.accessioned | 2025-06-12T09:36:52Z | |
| dc.date.available | 2025-06-12T09:36:52Z | |
| dc.date.issued | 2025 | |
| dc.identifier.citation | Endocrine, 2025, vol. 89, pag 817–825 | es |
| dc.identifier.uri | https://uvadoc.uva.es/handle/10324/75949 | |
| dc.description | Producción Científica | es |
| dc.description.abstract | Purpose Thyroid nodules are commonly evaluated using ultrasound-based risk stratification systems, which rely on sub-
jective descriptors. Artificial intelligence (AI) may improve assessment, but its effectiveness in non-subspecialist settings is
unclear. This study evaluated the impact of an AI-based decision support system (AI-DSS) on thyroid nodule ultrasound
assessments by general endocrinologists (GE) without subspecialty thyroid imaging training.
Methods A prospective cohort study was conducted on 80 patients undergoing thyroid ultrasound in GE outpatient clinics.
Thyroid ultrasound was performed based on clinical judgment as part of routine care by GE. Images were retrospectively
analyzed using an AI-DSS (Koios DS), independently of clinician assessments. AI-DSS results were compared with initial
GE evaluations and, when referred, with expert evaluations at a subspecialized thyroid nodule clinic (TNC). Agreement in
ultrasound features, risk classification by the American College of Radiology Thyroid Imaging Reporting and Data System
(ACR TI-RADS) and American Thyroid Association guidelines, and referral recommendations was assessed.
Results AI-DSS differed notably from GE, particularly assessing nodule composition (solid: 80%vs.36%,p < 0.01), echo-
genicity (hypoechoic:52%vs.16%,p < 0.01), and echogenic foci (microcalcifications:10.7%vs.1.3%,p < 0.05). AI-DSS
classification led to a higher referral rate compared to GE (37.3%vs.30.7%, not statistically significant). Agreement
between AI-DSS and GE in ACR TI-RADS scoring was moderate (r = 0.337;p < 0.001), but improved when comparing GE
to AI-DSS and TNC subspecialist (r = 0.465;p < 0.05 and r = 0.607;p < 0.05, respectively).
Conclusion In a non-subspecialist setting, non-adjunct AI-DSS use did not significantly improve risk stratification or reduce
hypothetical referrals. The system tended to overestimate risk, potentially leading to unnecessary procedures. Further
optimization is required for AI to function effectively in low-prevalence environment. | es |
| dc.format.mimetype | application/pdf | es |
| dc.language.iso | eng | es |
| dc.publisher | Springer | es |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject.classification | Thyroid nodule | es |
| dc.subject.classification | Artificial intelligence | es |
| dc.subject.classification | AI-DSS | es |
| dc.subject.classification | Ultrasound | es |
| dc.subject.classification | ACR TI-RADS | es |
| dc.subject.classification | ATA guidelines | es |
| dc.subject.classification | Risk stratification | es |
| dc.subject.classification | General endocrinology | es |
| dc.title | Preliminary analysis of AI-based thyroid nodule evaluation in a non-subspecialist endocrinology setting | es |
| dc.type | info:eu-repo/semantics/article | es |
| dc.rights.holder | © 2025 The Author(s) | es |
| dc.identifier.doi | 10.1007/s12020-025-04287-8 | es |
| dc.relation.publisherversion | https://link.springer.com/article/10.1007/s12020-025-04287-8 | es |
| dc.identifier.publicationtitle | Endocrine | es |
| dc.peerreviewed | SI | es |
| dc.description.project | Open access funding provided by FEDER European Funds and the Junta De Castilla y León under the Research and Innovation Strategy for Smart Specialization (RIS3) of Castilla y León 2021-2027. | es |
| dc.identifier.essn | 1559-0100 | es |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
| dc.subject.unesco | 32 Ciencias Médicas | es |